These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16377277)

  • 1. Serial angioscopic findings after successful intracoronary brachytherapy for in-stent restenosis.
    Okada M; Tamai H; Kyo E; Kosuga K; Hata T; Nakamura T; Fujita S; Tsuji T; Takeda S; Masunaga N; Motohara S; Uehata H
    Am J Cardiol; 2006 Jan; 97(1):21-5. PubMed ID: 16377277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis.
    Bagga R; Kini A; Lee P; Agarwal A; Duffy M; Kim M; Sharma S
    J Invasive Cardiol; 2005 Jun; 17(6):302-6. PubMed ID: 16003004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system. Initial experience in Latin America.
    Muñoz JS; Feres F; Abizaid AC; Mattos LA; Staico R; Centemero M; Tanajura LF; Pinto I; Sousa AG; Sousa JE
    Arq Bras Cardiol; 2004 Jul; 83(1):63-8; 57-62. PubMed ID: 15322668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice.
    Nikas DN; Kalef-Ezra J; Katsouras CS; Tsekeris P; Bozios G; Pappas C; Naka KK; Kotsia A; Papamichael N; Sideris DA; Michalis LK
    Int J Cardiol; 2007 Feb; 115(2):183-9. PubMed ID: 16890309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year clinical follow up after intracoronary radiation for the prevention of in-stent restenosis.
    Gruberg L; Caiati R; Aronson D; Suleiman M; Petchersky S; Nikolsky E; Grenadier E; Boulus M; Markiewicz W; Kerner A; Beyar R
    J Invasive Cardiol; 2006 Oct; 18(10):494-8. PubMed ID: 17042094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after intracoronary beta-radiation for the treatment of in-stent restenosis.
    Feres F; Munoz J; Abizaid A; Staico R; Kuwabara M; Mattos L; Centemero M; Maldonado G; Albertal M; Vaz VD; Ferreira E; Tanajura LF; Chaves A; Sousa A; Sousa JE
    J Invasive Cardiol; 2005 Sep; 17(9):473-7. PubMed ID: 16145235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial.
    Ribichini F; Ferrero V; Piessens M; Heyndrickx GR; de Bruyne B; Verbeke L; Matullo G; Büchi M; Piazza A; Guarrera S; Lüscher TF; Wijns W
    Cardiovasc Revasc Med; 2005; 6(1):7-13. PubMed ID: 16263350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
    Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
    J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery pseudoaneurysm after balloon angioplasty and intracoronary beta-radiation for in-stent restenosis.
    Dixon SR; Grines CL; Safian RD
    Catheter Cardiovasc Interv; 2004 Feb; 61(2):214-6. PubMed ID: 14755815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?
    Ruef J; Hofmann M; Störger H; Haase J
    Cardiovasc Revasc Med; 2007; 8(3):170-4. PubMed ID: 17765646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation.
    Takano M; Ohba T; Inami S; Seimiya K; Sakai S; Mizuno K
    Eur Heart J; 2006 Sep; 27(18):2189-95. PubMed ID: 16893918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intracoronary irradiation after de novo stent implantation results of the EVEREST (Evaluation of Endoluminal Radiation in Elective Stenting) trial.
    Geiger MH; Ludwig J; Burckhard R; Scheinert D; Müller RG; Daniel WG; Sauer R; Strnad V
    Strahlenther Onkol; 2006 Jan; 182(1):9-15. PubMed ID: 16404515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
    Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW;
    Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained attenuation of neointimal coverage over the stent following brachytherapy for in-stent restenosis: angioscopic findings.
    Awata M; Kotani J; Nanto S; Uematsu M; Morozumi T; Hori M; Nagata S
    Circ J; 2006 Jul; 70(7):846-50. PubMed ID: 16799236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis.
    Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.